Phillips-Medisize, a Molex company, broke ground on a new state-of-the-art manufacturing facility in Hudson, WI. Located on the site of a former greyhound racetrack, it is expected to support at least 230,000 square feet of manufacturing space for FDA-regulated products, according to a press release. The groundbreaking ceremony took place on Feb. 15 with Hudson Mayor Rich O’Conner and community and company representatives in attendance.
Phillips-Medisize describes itself as an end-to-end provider of innovation, development and manufacturing solutions to the pharmaceutical, diagnostics, medical device and specialty commercial market segments. Backed by the combined global resources of Molex and its parent company Koch Industries, Phillips-Medisize currently employs more than 5,500 people at 26 manufacturing sites around the world.
“The St. Croix Meadows redevelopment is aimed at transforming [Hudson's] riverfront community,” said Mayor O'Connor. "By creating employment opportunities with Phillips-Medisize, I hope to encourage young people to stay in Hudson.”
Phillips-Medisize St. Croix Meadows facility is slated for completion by mid-2020. The company expects to hire more than 250 employees in positions ranging from skilled manufacturing to engineering by the time construction is completed. It currently employs more than 1,000 people in Wisconsin, where it was founded more than five decades ago.
“We are proud to invest in growing Phillips-Medisize’s manufacturing presence in our founding state of Wisconsin,” said Matt Jennings, CEO and President. “Hudson has been home to Phillips-Medisize for the past 36 years, so we are excited to reinforce our commitment to the vibrant community with our St. Croix Meadows facility.”
Situated on a 34-acre site, the St. Croix Meadows facility will be the company’s single largest operation in the state, with ample room for additional expansion.
The manufacturing facility will be FDA-registered, adhering to cleanroom practices and featuring state-of-the-art equipment to meet quality production standards, said Phillips-Medisize.